[Autoimmune diseases and cancers. Part I: cancers complicating autoimmune diseases and their treatment]

[Auto-immune diseases and cancers. Second part: auto-immune diseases complicating cancers and their treatment]

Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients

Myocarditis in adult-onset still disease

Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients

[Recurrent aseptic meningitis secondary to nonsteroidal anti-inflammatory drugs in a patient with lupus]

A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study

[Systemic sclerosis in men]

Clinical significance of anti-histidyl-tRNA synthetase (Jo1) autoantibodies

[Septic arthritis caused by Aeromonas hydrophila]

Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe de Recherche sur l'Artérite à Cellules Géantes

Giant cell arteritis and polymyalgia rheumatica: are pregnancies a protective factor? A prospective, multicentre case-control study. GRACG (Groupe de Recherche sur l'Artérite à Cellules Géantes)

Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes

Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes

[Bilateral perception deafness in adult onset Still disease]

[Intravascular malignant lymphoma (ex-malignant angioendotheliosis). 3 cases]

[Clinical study and diagnostic criteria of periarteritis nodosa. Apropos of 27 cases]

Subclavian and axillary involvement in temporal arteritis and polymyalgia rheumatica

[Distribution of HLA-DR antigens in unrelated giant cell arteritis]

[Involvement of arterial trunks of the upper limbs in giant cell arteritis. Apropos of 7 cases]

[Aortic insufficiencies in ankylosing spondylarthritis. Clinical study and prognosis of 12 cases]

[Aortic valve insufficiencies in ankylosing spondylarthritis. Prognosis and therapeutic indications apropos of 12 cases]

Bone marrow involvement in systemic lupus erythematosus

[Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion]

[Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion]

[Ascitis associated with ischemic bowel revealing systemic lupus]

Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus

Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies

Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 cases

[Systemic lupus erythematosus and/or relapsing polychondritis with catastrophic antiphospholipid syndrome]

[Systemic lupus erythematosus with disease onset after age 65]

Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life

Long-Term Followup of a Multicenter Cohort of 101 Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)

Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis

Marked improvement of Churg-Strauss vasculitis with intravenous gamma globulins during pregnancy

[Cytoplasm antibodies of polynuclear neutrophils in Wegener's granulomatosis and systemic vasculitis]

Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life

Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis

Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report

[Horton's disease, polymyalgia rheumatica, and cardiovascular risk factors. A case-control, prospective multicenter study]

[Immunogenetics of Horton's disease and of rhizomelic pseudo-polyarthritis]

[Subclavian and axillary arteritis in Horton's disease and rhizomelic pseudopolyarthritis. 10 cases]

Impairment of quality of life in patients with antiphospholipid syndrome

Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies

[Systemic lupus erythematosus and/or relapsing polychondritis with catastrophic antiphospholipid syndrome]

[Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion]

[Horton's disease, polymyalgia rheumatica, and cardiovascular risk factors. A case-control, prospective multicenter study]

Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy

Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study

Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy

[Thymoma and primary Gougerot-Sjögren syndrome progressing to severe bronchiolitis]